{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T18:27:45Z","timestamp":1786991265629,"version":"build-2736575974"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["jaci-global.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology: Global"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jacig.2024.100317","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T20:34:25Z","timestamp":1722458065000},"page":"100317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4169-1309","authenticated-orcid":false,"given":"Makiko","family":"Kido-Nakahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Onozuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Izuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidehisa","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Nunomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoi","family":"Takenaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mai","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoko","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rai","family":"Fujimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sakae","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eishin","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michihiro","family":"Hide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuro","family":"Okano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomomitsu","family":"Miyagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natsuko","family":"Aoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko","family":"Nakajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ichiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoko","family":"Tonomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinobu","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Risa","family":"Tamagawa-Mineoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Masuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Takeichi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yozo","family":"Ishiuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michie","family":"Katsuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiharu","family":"Tateishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimichi","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haruna","family":"Matsuda-Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keiji","family":"Tanese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mamitaro","family":"Ohtsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Kamiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yudai","family":"Kabata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riichiro","family":"Abe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Mitsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuyoshi","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaku","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masutaka","family":"Furue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norito","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Nakahara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacig.2024.100317_bib1","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1111\/all.12049","article-title":"Atopic dermatitis 2.0: from the clinical phenotype to the molecular taxonomy and stratified medicine","volume":"67","author":"Bieber","year":"2012","journal-title":"Allergy"},{"key":"10.1016\/j.jacig.2024.100317_bib2","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.alit.2016.12.002","article-title":"Atopic dermatitis: immune deviation, barrier dysfunction, IgE autoreactivity and new therapies","volume":"66","author":"Furue","year":"2017","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2024.100317_bib3","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/imr.12545","article-title":"The interplay between genetic and environmental factors in the pathogenesis of atopic dermatitis","volume":"278","author":"Otsuka","year":"2017","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jacig.2024.100317_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaci.2018.10.032","article-title":"Atopic dermatitis endotypes and implications for targeted therapeutics","volume":"143","author":"Czarnowicki","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100317_bib5","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.alit.2020.02.006","article-title":"The Japanese Dermatology Association. Japanese guidelines for atopic dermatitis 2020","volume":"69","author":"Katoh","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2024.100317_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.anai.2020.08.016","article-title":"New treatments in atopic dermatitis","volume":"126","author":"Puar","year":"2021","journal-title":"Ann Allergy Asthma Immunol"},{"key":"10.1016\/j.jacig.2024.100317_bib7","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa1610020","article-title":"Two phase 3 trials of dupilumab versus placebo in atopic dermatitis","volume":"15","author":"Simpson","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacig.2024.100317_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1001\/jamadermatol.2019.3617","article-title":"Efficacy and safety of multiple dupilumab dose regimens after initial successful treatment in patients with atopic dermatitis: a randomized clinical trial","volume":"156","author":"Worm","year":"2020","journal-title":"JAMA Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib9","doi-asserted-by":"crossref","DOI":"10.2340\/actadv.v101.369","article-title":"Efficacy of dupilumab for atopic dermatitis according to clinical course and clinical findings: a multicentre retrospective study","volume":"101","author":"Nakahara","year":"2021","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jacig.2024.100317_bib10","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/cea.13954","article-title":"Dupilumab suppresses type 2 inflammatory biomarkers across multiple atopic, allergic diseases","volume":"51","author":"Hamilton","year":"2021","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2024.100317_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.xjidi.2021.100042","article-title":"Literature review of real-world effectiveness and safety of dupilumab for atopic dermatitis","volume":"1","author":"Kamata","year":"2021","journal-title":"JID Innov"},{"key":"10.1016\/j.jacig.2024.100317_bib12","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000022043","article-title":"Exploration of biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab: a study protocol","volume":"99","author":"Nakahara","year":"2020","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.jacig.2024.100317_bib13","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/cea.14267","article-title":"Exploring biomarkers to predict clinical improvement of atopic dermatitis in patients treated with dupilumab (B-PAD study)","volume":"53","author":"Nakahara","year":"2023","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.jacig.2024.100317_bib14","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1034\/j.1600-0625.2001.100102.x","article-title":"The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis","volume":"10","author":"Hanifin","year":"2001","journal-title":"EASI Evaluator Group. Exp Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib15","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1111\/bjd.13662","article-title":"What the Eczema Area and Severity Index score tells us about the severity of atopic dermatitis: an interpretability study","volume":"172","author":"Leshem","year":"2015","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib16","first-page":"540","article-title":"Standardized reporting of the Eczema Area and Severity Index (EASI) and the Patient-Oriented Eczema Measure (POEM): a recommendation by the Harmonising Outcome Measures for Eczema (HOME) Initiative","volume":"179","author":"Grinich","year":"2018","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib17","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/bjd.12590","article-title":"Translating Patient-Oriented Eczema Measure (POEM) scores into clinical practice by suggesting severity strata derived using anchor-based methods","volume":"169","author":"Charman","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib18","doi-asserted-by":"crossref","first-page":"978","DOI":"10.2340\/00015555-2433","article-title":"Itch assessment with Visual Analogue Scale and Numerical Rating Scale: determination of minimal clinically important difference in chronic itch","volume":"96","author":"Reich","year":"2016","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jacig.2024.100317_bib19","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bjd.17744","article-title":"Peak Pruritus Numerical Rating Scale: psychometric validation and responder definition for assessing itch in moderate-to-severe atopic dermatitis","volume":"181","author":"Yosipovitch","year":"2019","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib20","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/j.jacig.2024.100317_bib21","first-page":"37","article-title":"Assessment of 2 \u00d7 2 associations: generalization of signal-detection methodology","volume":"42","author":"Kraemer","year":"1988","journal-title":"Am Statist"},{"key":"10.1016\/j.jacig.2024.100317_bib22","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/1346-8138.15464","article-title":"Higher baseline serum lactate dehydrogenase level is associated with poor effectiveness of dupilumab in the long term in patients with atopic dermatitis","volume":"47","author":"Kato","year":"2020","journal-title":"J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4168\/aair.2021.13.5.733","article-title":"Real clinical practice data of monthly dupilumab therapy in adult patients with moderate-to-severe atopic dermatitis: clinical efficacy and predictive markers for a favorable clinical response","volume":"13","author":"Lee","year":"2021","journal-title":"Allergy Asthma Immunol Res"},{"key":"10.1016\/j.jacig.2024.100317_bib24","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/jdv.18919","article-title":"Prevalence of and association between atopic dermatitis and food sensitivity, food allergy and challenge-proven food allergy: a systematic review and meta-analysis","volume":"37","author":"Christensen","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jacig.2024.100317_bib25","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1124\/jpet.122.001482","article-title":"Alterations in brain neural network and stress system in atopic dermatitis: novel therapeutic interventions","volume":"385","author":"Nakagawa","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jacig.2024.100317_bib26","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5492\/wjccm.v12.i3.92","article-title":"Sleep during and following critical illness: a narrative review","volume":"12","author":"Showler","year":"2023","journal-title":"World J Crit Care Med"},{"key":"10.1016\/j.jacig.2024.100317_bib27","doi-asserted-by":"crossref","first-page":"349","DOI":"10.18176\/jiaci.0320","article-title":"Neuropathic pain and itch mechanisms underlying allergic conjunctivitis","volume":"29","author":"Kuruvilla","year":"2019","journal-title":"J Investig Allergol Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100317_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.03.036","article-title":"Periostin activation of integrin receptors on sensory neurons induces allergic itch","volume":"31","author":"Mishra","year":"2020","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacig.2024.100317_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.111933","article-title":"Periostin activates distinct modules of inflammation and itching downstream of the type 2 inflammation pathway","volume":"42","author":"Nunomura","year":"2023","journal-title":"Cell Rep"},{"key":"10.1016\/j.jacig.2024.100317_bib30","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2332\/allergolint.13-RAI-0663","article-title":"Periostin in allergic inflammation","volume":"63","author":"Izuhara","year":"2014","journal-title":"Allergol Int"},{"key":"10.1016\/j.jacig.2024.100317_bib31","doi-asserted-by":"crossref","first-page":"2338","DOI":"10.1016\/j.jid.2021.03.009","article-title":"Periostin, an emerging player in itch sensation","volume":"141","author":"Hashimoto","year":"2021","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib32","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/bjd.12943","article-title":"Periostin levels correlate with disease severity and chronicity in patients with atopic dermatitis","volume":"171","author":"Kou","year":"2014","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/bjd\/ljad032","article-title":"Serum biomarker-based endotypes of atopic dermatitis in China and prediction for efficacy of dupilumab","volume":"188","author":"Wu","year":"2023","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jacig.2024.100317_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jaci.2020.04.062","article-title":"Confirmation of multiple endotypes in atopic dermatitis based on serum biomarkers","volume":"147","author":"Bakker","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.jacig.2024.100317_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/dth.15255","article-title":"Dupilumab-induced psoriasis in a patient with atopic dermatitis and alopecia totalis: a case report and literature review","volume":"35","author":"Flanagan","year":"2022","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jacig.2024.100317_bib36","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.3390\/jcm12196291","article-title":"\u201cDe novo\u201d psoriasis and relapse of psoriasis induced by dupilumab: three new cases and review of the literature","volume":"12","author":"Trave","year":"2023","journal-title":"J Clin Med"}],"container-title":["Journal of Allergy and Clinical Immunology: Global"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772829324001139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T12:49:22Z","timestamp":1731329362000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772829324001139"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2772829324001139"],"URL":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100317","relation":{},"ISSN":["2772-8293"],"issn-type":[{"value":"2772-8293","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biomarkers and patient-related factors associated with clinical outcomes in dupilumab-treated atopic dermatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology: Global","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacig.2024.100317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}],"article-number":"100317"}}